Cancer Drug's Long-Term survival test begins
NCT ID NCT07405164
Summary
This study aims to learn about the long-term effects of the cancer drug belzutifan. It is for people who are already taking belzutifan in other related trials for advanced solid tumors or cancers linked to a genetic condition called VHL disease. The main goal is to see how long people live after starting the treatment and to monitor its long-term safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VON HIPPEL-LINDAU DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.